| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Altimmune, Inc. | Chief Financial Officer | Common Stock, par value $0.0001 | 17,721 | $199,361 | $11.25 | 31 Jul 2021 | Direct |
| ObsEva SA | Interim CEO and CFO | Employee Stock Option (right to buy) | 250,000 | 23 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| OBSV | ObsEva SA | 23 Feb 2023 | 1 | $0 | 4 | Interim CEO and CFO | 24 Feb 2023, 15:50 |
| OBSV | ObsEva SA | 01 Jan 2023 | 0 | $0 | 3 | Chief Financial Officer | 03 Jan 2023, 15:23 |
| ALT | Altimmune, Inc. | 31 Jul 2021 | 1 | +$6,191 | 4 | Chief Financial Officer | 06 Aug 2021, 19:01 |